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Relapse of infantile haemangiomas in children 
treated with oral propranolol
This study by Ahogo et al. is the first to investigate factors 
associated with the risk of relapse in children with infantile 
haemangioma (IH) treated with propranolol after cessation of 
treatment. This was a single-centre retrospective observation-
al study. All files and photographs of patients with IH aged ≤ 5 
months at the time of treatment initiation were studied during 
a period of 42 months. In total 158 children were included, 
of whom 118 had not relapsed and 40 had relapsed. Fifty-
two patients were boys and 106 were girls (male-to-female 
ratio 1 : 2); 19 (12%) had segmental IH. Multivariate analysis 
indicated that only IHs with a subcutaneous component and 
those with a segmental distribution were independently asso-
ciated with relapse. 
The authors concluded that segmental IHs and those with 
a deeper component were more at risk of relapse and mer-
ited closer follow-up after treatment interruption, and/or a 
longer treatment period. Br J Dermatol 2013; 169: 1252–56. 
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Reticular erythematous mucinosis
Rongioletti et al. set out to improve the characterization of 
reticular erythematous mucinosis (REM), a rare skin disease 
previously studied only in single case reports or small case 
series. This study is the largest case series of patients with 
REM to date. The authors collated the demographics, clini-
cal and pathological features, comorbidities, treatment and 
clinical course in a retrospective and prospective study on 
25 patients diagnosed with REM in the setting of a universi-
ty-affiliated dermatology and dermatopathology centre. The 
study determined that this condition is characterized clini-
cally by a reticular pattern with involvement of the midline 
chest and back, and a predilection for middle-aged women. 
The role of sun exposure in REM remains uncertain, as is the 
possible association with other conditions such as malig-
nancy and thyroid dysfunction. Immunological studies in 
this series were noncontributory. The therapeutic response 
to antimalarial treatment was stated to be good in > 80% 
of cases. Furthermore, worsening or recurrence of the rash 
after treatment discontinuation, or in the course of the dis-
ease, occurred in 31% of patients. Br J Dermatol 2013; 169: 
1207–11.
Measures of actinic keratoses
Chen et al. state that enumeration of actinic keratoses (AKs) 
is highly variable but important to standardize as new ther-
apies are emerging. They set out to assess the reliability of 
four different methods used to quantify AKs and to investi-
gate whether a consensus meeting affected the reliability. 
The study consisted of a single-blinded study of 12 experi-
enced dermatologist raters counting AKs on the face and ears 
of nine subjects before and after a consensus meeting. The 
intraclass correlation coefficient (ICC) among raters for pre- 
and postconsensus evaluations was the primary outcome 
measure. They reported that of the four assessment methods, 
the ‘total count’ method had the greatest ICC for both pre- 
(0.18, P = 0.04) and postconsensus (0.66, P ≤ 0.0001) assess-
ments. Total count was also the only preconsensus evaluation 
for which the null hypothesis of no association among assess-
ments was rejected. They concluded that total AK count 
appears to be the most reliable measure of quantifying AKs 
on the face and ears, and that educational consensus discus-
sion prior to assessment improves the reliability of this mea-
sure. Br J Dermatol 2013; 169: 1219–22.
Histological regression in primary melanoma
Ribero et al. describe how regression has previously been 
considered a negative prognostic factor, by preventing prop-
er melanoma thickness measurement. They state that there 
is also no consensus regarding the need for sentinel lymph 
node biopsy (SLNB) when regression is present within the 
primary tumour. The stated aim of this study was to ascer-
tain the utility of SLNB in thin melanoma and to clarify the 
significance of regression in disease-free survival and overall 
survival in the authors’ own case series. They analysed data 
collected from 1693 consecutive patients with American 
Joint Committee on Cancer (AJCC) stage I–II melanoma. 
SLNB was performed in 656 of the 1693 patients. Regression 
was present in 349 patients, and 223 of the cases were char-
acterized by thin lesions. SLNB was performed in 104 cases 
of thin melanoma with regression. The majority of regional 
lymph node metastases were observed in patients who did 
not undergo SLNB (89 out of 132). Among the remaining 43 
‘false negative’ patients, only three showed regression in the 
primary. The authors concluded that regression alone should 
not be a reason to perform SLNB in thin melanoma; on the 
contrary, they state that regression can now be considered a 
favourable prognostic factor in patients with AJCC stage I–II 
melanoma. Br J Dermatol 2013; 169: 1240–45.
